XML 28 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:      
Research and development, net $ 27,990 $ 30,553 $ 16,954
Marketing and business development 2,888 2,983 1,614
General and administrative 8,010 9,609 7,704
Operating loss 38,888 43,145 26,272
Financial (income) expense, net 540 (544) 10,597
Loss before income tax 39,428 42,601 36,869
Income tax expense 129
Net loss 39,557 42,601 36,869
Deemed dividend 2,114
Net loss attributable to Ordinary shares $ 39,557 $ 42,601 $ 38,983
Basic and diluted net loss per Ordinary share (in Dollars per share) $ 2.04 $ 2.28 $ 4.48
Weighted average number of Ordinary shares used in computing basic and diluted loss per share (in Shares) 19,426,692 18,721,528 9,582,405